abstract |
We disclose growth hormone fusion proteins with increased in vivo stability and activity, nucleic acid molecules encoding said proteins, and methods of treatment of growth hormone related diseases that would benefit from growth hormone agonists or antagonists. [Selection] Figure 36 |